Christoph Gesenberg

522 total citations
15 papers, 302 citations indexed

About

Christoph Gesenberg is a scholar working on Pharmaceutical Science, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Christoph Gesenberg has authored 15 papers receiving a total of 302 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pharmaceutical Science, 5 papers in Organic Chemistry and 3 papers in Computational Theory and Mathematics. Recurrent topics in Christoph Gesenberg's work include Drug Solubulity and Delivery Systems (7 papers), Computational Drug Discovery Methods (3 papers) and Gastroesophageal reflux and treatments (2 papers). Christoph Gesenberg is often cited by papers focused on Drug Solubulity and Delivery Systems (7 papers), Computational Drug Discovery Methods (3 papers) and Gastroesophageal reflux and treatments (2 papers). Christoph Gesenberg collaborates with scholars based in United States, Germany and Sweden. Christoph Gesenberg's co-authors include Martin Saunders, Hugo A. Jiménez‐Vázquez, W. E. Billups, Alexander Gonzalez, R. J. Cross, François Diederich, Andreas Herrmann, Wang Luo, Robert C. Haddon and Xueqing Chen and has published in prestigious journals such as Journal of the American Chemical Society, Pharmaceutical Research and Journal of Pharmaceutical Sciences.

In The Last Decade

Christoph Gesenberg

14 papers receiving 280 citations

Peers

Countries citing papers authored by Christoph Gesenberg

Since Specialization

Citations

This map shows the geographic impact of Christoph Gesenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christoph Gesenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christoph Gesenberg more than expected).

Fields of papers citing papers by Christoph Gesenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christoph Gesenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christoph Gesenberg. The network helps show where Christoph Gesenberg may publish in the future.

Co-authorship network of co-authors of Christoph Gesenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Christoph Gesenberg. A scholar is included among the top collaborators of Christoph Gesenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christoph Gesenberg. Christoph Gesenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

#	Work	Indexed citations
1	Hydrolysis of cellulose acetate phthalate and hydroxypropyl methylcellulose phthalate in amorphous solid dispersions 2024 ·Journal of Pharmaceutical Sciences ·Jinghan Li, (unknown), (unknown), Laura I. Mosquera-Giraldo, (unknown), Kimberly A. Foster, Christoph Gesenberg	0
2	Solvent-Casted Films to Assist Polymer Selection for Amorphous Solid Dispersions During Preclinical Studies: In-vitro and In-vivo Exploration 2021 ·Pharmaceutical Research ·Laura I. Mosquera-Giraldo, (unknown), Kevin Stefanski, Kimberly A. Foster, Christoph Gesenberg, (unknown), Ying Ren, Anne Rose, (unknown), Asoka Ranasinghe	3
3	Utilization of In Vitro, In Vivo and In Silico Tools to Evaluate the pH-Dependent Absorption of a BCS Class II Compound and Identify a pH-Effect Mitigating Strategy 2019 ·Pharmaceutical Research ·Christoph Gesenberg, Neil Mathias, Yan Xu, John R. Crison, (unknown), (unknown), David Good, (unknown), Ajit S. Narang, Richard Schartman, Naiyu Zheng, (unknown), Jatin Patel	15
4	Preclinical Pharmacokinetics and In Vitro Metabolism of BMS-605339: A Novel HCV NS3 Protease Inhibitor 2014 ·Journal of Pharmaceutical Sciences ·Susan Jenkins, Paul M. Scola, Fiona McPhee, Jay O. Knipe, Christoph Gesenberg, (unknown), Vinod Arora, Gary D. Pilcher, Kenneth S. Santone	6
5	Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitor 2013 ·Bioorganic & Medicinal Chemistry Letters ·Chunjian Liu, James C. Lin, (unknown), Christoph Gesenberg, Hongjian Zhang, Punit H. Marathe, Mary F. Malley, Michael A. Galella, Murray McKinnon, John H. Dodd, Joel C. Barrish, Gary L. Schieven, Katerina Leftheris	8
6	Assessing the Risk of pH-Dependent Absorption for New Molecular Entities: A Novel in Vitro Dissolution Test, Physicochemical Analysis, and Risk Assessment Strategy 2013 ·Molecular Pharmaceutics ·Neil Mathias, Yan Xu, Dhaval Patel, Michael Graß, (unknown), (unknown), Jim Mullin, (unknown), John R. Crison, (unknown), Christoph Gesenberg, J. S. Morrison, Balvinder S. Vig, Krishnaswamy Raghavan	53
7	A high-throughput spectrophotometric approach for evaluation of precipitation resistance 2011 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Christoph Gesenberg, Jaquan K. Levons, Michael Hubert, Krishnaswamy Raghavan	12
8	Utilization of in vitro Caco‐2 permeability and liver microsomal half‐life screens in discovering BMS‐488043, a novel HIV‐1 attachment inhibitor with improved pharmacokinetic properties 2009 ·Journal of Pharmaceutical Sciences ·Zheng Yang, Lisa Zadjura, Anthony M. Marino, Celia D’Arienzo, Jacek Malinowski, Christoph Gesenberg, Pin‐Fang Lin, Richard J. Colonno, Tao Wang, John F. Kadow, Nicholas A. Meanwell, Steven Hansel	16
9	Discovery pharmaceutics—Challenges and opportunities 2006 ·The AAPS Journal ·Xueqing Chen, (unknown), Christoph Gesenberg, Olafur Gudmundsson	32
10	Discovery Pharmaceutics—Challenges and Opportunities 2006 ·The AAPS Journal ·(unknown), (unknown), Christoph Gesenberg, (unknown)	2
11	3He NMR spectra of highly reduced C60 1997 ·Tetrahedron Letters ·W. E. Billups, Alexander Gonzalez, Christoph Gesenberg, (unknown), (unknown), Lawrence B. Alemany, Martin Saunders, Hugo A. Jiménez‐Vázquez, Anthony Khong	26
12	A new methylenecyclopropene synthesis and the isolation of a novel methylenecyclopropene dimer 1997 ·Tetrahedron Letters ·W. E. Billups, Christoph Gesenberg, R. David Cole	6
13	Reactivity of cyclopentenyl anion analogous heterocycles: 1,5‐electrocyclization of 2‐oxa‐, 2‐thia‐, 2‐aza‐ and 2‐phosphabicyclo[3.2.0]hept‐3‐ene. A sigmatropic [1,3] carbon shift 1995 ·Liebigs Annalen ·Frank‐Gerrit Klärner, (unknown), (unknown), Christoph Gesenberg, (unknown)	5
14	Analysis of Isomers of the Higher Fullerenes by 3He NMR Spectroscopy 1995 ·Journal of the American Chemical Society ·Martin Saunders, Hugo A. Jiménez‐Vázquez, R. J. Cross, W. E. Billups, Christoph Gesenberg, Alexander Gonzalez, Wang Luo, Robert C. Haddon, François Diederich, Andreas Herrmann	101
15	Reaction of cyclopropa[b]naphthalene with 3He@C60 1994 ·Tetrahedron Letters ·Martin Saunders, Hugo A. Jiménez‐Vázquez, R. J. Cross, (unknown), Christoph Gesenberg, (unknown)	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact